| scholarly article | Q13442814 |
| P50 | author | Leah A Marquez-Curtis | Q45962325 |
| Anna Janowska-Wieczorek | Q87734986 | ||
| P2093 | author name string | Jianping Wen | |
| Shirley Ma | |||
| Gonzalo Hortelano | |||
| Megan Dodd | |||
| Bahareh Sayyar | |||
| P2860 | cites work | Single-cell hydrogel encapsulation for enhanced survival of human marrow stromal cells. | Q45930948 |
| Characterization of viability and proliferation of alginate-poly-L-lysine-alginate encapsulated myoblasts using flow cytometry. | Q50444100 | ||
| Migration of Bone Marrow and Cord Blood Mesenchymal Stem Cells In Vitro Is Regulated by Stromal-Derived Factor-1-CXCR4 and Hepatocyte Growth Factor-c-met Axes and Involves Matrix Metalloproteinases | Q57375767 | ||
| Haemophilia B: impact on patients and economic burden of disease | Q64041202 | ||
| Human fibroblasts bind directly to fibrinogen at RGD sites through integrin alpha(v)beta3 | Q73320343 | ||
| Comparison of cellular functionality of human mesenchymal stromal cells and PBMC | Q79955430 | ||
| Expansion of mesenchymal stem cells on fibrinogen-rich protein surfaces derived from blood plasma | Q84578449 | ||
| Biomimetic materials for tissue engineering | Q28202115 | ||
| Get a ligand, get a life: integrins, signaling and cell survival | Q28645744 | ||
| Gene therapy for hemophilia. | Q33838660 | ||
| Anoikis | Q33978500 | ||
| Cell encapsulation: promise and progress | Q34168860 | ||
| AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. | Q34168942 | ||
| Anoikis: roadblock to cell transplantation? | Q34169271 | ||
| Biocompatibility of alginate-poly-L-lysine microcapsules for cell therapy | Q34507010 | ||
| Molecular mechanisms of "detachment-induced apoptosis--Anoikis". | Q34629157 | ||
| Bioactive cell-hydrogel microcapsules for cell-based drug delivery. | Q34974084 | ||
| Encapsulated human mesenchymal stem cells: a unique hypoimmunogenic platform for long-term cellular therapy | Q35000974 | ||
| Haemophilias A and B. | Q35143113 | ||
| Adenovirus-associated virus vector-mediated gene transfer in hemophilia B | Q35691659 | ||
| Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins | Q36294082 | ||
| Differential roles for alpha(M)beta(2) integrin clustering or activation in the control of apoptosis via regulation of akt and ERK survival mechanisms | Q36360375 | ||
| Mesenchymal stem cells: biology and clinical potential in type 1 diabetes therapy | Q37094023 | ||
| A new adenoviral helper-dependent vector results in long-term therapeutic levels of human coagulation factor IX at low doses in vivo | Q38495950 | ||
| Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. | Q40097346 | ||
| Persistent delivery of factor IX in mice: gene therapy for hemophilia using implantable microcapsules | Q40948692 | ||
| Delivery of human factor IX in mice by encapsulated recombinant myoblasts: a novel approach towards allogeneic gene therapy of hemophilia B. | Q41191600 | ||
| Integrins and anoikis | Q41612562 | ||
| Effects of plating density and culture time on bone marrow stromal cell characteristics. | Q42188573 | ||
| Gene therapy. Panel reviews risks of germ line changes | Q43492733 | ||
| Harmful potential of viral vectors fuels doubts over gene therapy | Q45862715 | ||
| Encapsulated human primary myoblasts deliver functional hFIX in hemophilic mice. | Q45871067 | ||
| Sustained and therapeutic delivery of factor IX in nude haemophilia B mice by encapsulated C2C12 myoblasts: concurrent tumourigenesis. | Q45875852 | ||
| Growth of recombinant fibroblasts in alginate microcapsules | Q45878839 | ||
| Sustained and therapeutic levels of human factor IX in hemophilia B mice implanted with microcapsules: key role of encapsulated cells | Q45888869 | ||
| P433 | issue | 1 | |
| P921 | main subject | mesenchymal stem cell | Q1922379 |
| P304 | page(s) | 2041731412462018 | |
| P577 | publication date | 2012-11-02 | |
| P1433 | published in | Journal of Tissue Engineering | Q6296005 |
| P1476 | title | Encapsulation of factor IX-engineered mesenchymal stem cells in fibrinogen-alginate microcapsules enhances their viability and transgene secretion | |
| P478 | volume | 3 |
| Q46334604 | Behaviour and ultrastructure of human bone marrow-derived mesenchymal stem cells immobilised in alginate-poly-l-lysine-alginate microcapsules |
| Q92074788 | Cell Encapsulation Within Alginate Microcapsules: Immunological Challenges and Outlook |
| Q38090923 | Encapsulated stem cells for cancer therapy |
| Q50995320 | Evaluation of different RGD ligand densities in the development of cell-based drug delivery systems. |
| Q28081911 | Gene therapy for hemophilia |
| Q26799475 | Mesenchymal stromal cells derived from various tissues: Biological, clinical and cryopreservation aspects |
| Q35031929 | Single-step laser-based fabrication and patterning of cell-encapsulated alginate microbeads |
| Q38982780 | Sustained expression of coagulation factor IX by modified cord blood-derived mesenchymal stromal cells |
| Q37722108 | Targeted introduction and effective expression of hFIX at the AAVS1 locus in mesenchymal stem cells |
| Q39038615 | The synergistic effects of the RGD density and the microenvironment on the behavior of encapsulated cells: in vitro and in vivo direct comparative study. |
| Q37419249 | Utilizing core-shell fibrous collagen-alginate hydrogel cell delivery system for bone tissue engineering. |
Search more.